MitraClip system is the only catheter-based device for percutanoeus mitral valve repair available for clinical use, after receipt of the CE Mark in 2008, while it is currently under review for FDA approval in the US. To date, over 3500 MitraClip implants have been performed worldwide, mainly in high risk surgical patients. The aim of this review is to review all the current evidences of the MitraClip therapy in an aim to define its clinical role in the treatment of mitral regurgitation (MR).
|Number of pages||9|
|Publication status||Published - Feb 2012|
- Clinical trials as topic
- Mitral valve annuloplasty
- Mitral valve insufficiency
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine